Cargando…
Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease
Non-alcoholic fatty liver disease (NAFLD) and Alcoholic Liver Disease (ALD) are major causes of liver-related morbidity and mortality and constitute important causes of liver transplantation. The spectrum of the liver disease is wide and includes isolated steatosis, steatohepatitis, and cirrhosis. T...
Autores principales: | Vonghia, Luisa, Van Herck, Mikhaïl A., Weyler, Jonas, Francque, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446913/ https://www.ncbi.nlm.nih.gov/pubmed/30972062 http://dx.doi.org/10.3389/fimmu.2019.00563 |
Ejemplares similares
-
The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
por: Van Herck, Mikhaïl A., et al.
Publicado: (2019) -
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
por: Francque, Sven, et al.
Publicado: (2019) -
Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
por: Vonghia, Luisa, et al.
Publicado: (2013) -
Non-Alcoholic Steatohepatitis Decreases Microsomal Liver Function in the Absence of Fibrosis
por: Verlinden, Wim, et al.
Publicado: (2020) -
Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide
por: Van Herck, Mikhaïl A., et al.
Publicado: (2017)